Estimation of utility weights for human papilloma virus-related health states according to disease severity

Ock, Minsu; Park, Jeong-Yeol; Son, Woo-Seung; Lee, Hyeon-Jeong; Kim, Seon-Ha; Jo, Min-Woo

doi:10.1186/s12955-016-0566-8

Health and Quality of Life Outcomes

Table 4 Utility weights derived from the VAS and SG according to socio-demographic factors and clinical information

From: Estimation of utility weights for human papilloma virus-related health states according to disease severity

		Scenario 1		Scenario 2		Scenario 3		Scenario 4		Scenario 5		Scenario 6		Scenario 7		Scenario 8
		VAS	SG	VAS	SG	VAS	SG	VAS	SG	VAS	SG	VAS	SG	VAS	SG	VAS	SG
Gender	Male	0.74	0.84	0.60	0.78	0.59	0.77	0.59	0.70	0.50	0.64	0.41	0.59	0.18	0.41	0.67	0.78
Gender	Female	0.73	0.82	0.61	0.77	0.61	0.77	0.59	0.71	0.51	0.67	0.43	0.60	0.18	0.44	0.66	0.77
Age group	19–29	0.73	0.85	0.61	0.78	0.60	0.81	0.60	0.76	0.46	0.70	0.43	0.65	0.17	0.44	0.63	0.82
	30–39	0.76	0.84	0.59	0.76	0.60	0.80	0.59	0.71	0.52	0.64	0.43	0.57	0.20	0.43	0.67	0.77
	40–49	0.72	0.85	0.62	0.78	0.62	0.75	0.60	0.67	0.50	0.63	0.41	0.58	0.18	0.42	0.66	0.76
	50–59	0.75	0.84	0.61	0.80	0.58	0.78	0.57	0.73	0.51	0.69	0.42	0.61	0.19	0.45	0.66	0.82
	≥60	0.71	0.79	0.61	0.75	0.62	0.73	0.60	0.67	0.52	0.62	0.42	0.59	0.17	0.39	0.69	0.72
Education level	High school or below	0.73	0.83	0.61	0.77	0.61	0.77	0.59	0.69	0.51	0.66	0.43	0.60	0.18	0.42	0.67	0.77
Education level	College or above	0.76	0.84	0.61	0.80	0.60	0.79	0.59	0.74	0.48	0.61	0.40	0.59	0.17	0.43	0.66	0.80
Occupation	Non-manual	0.77*	0.88	0.63	0.77	0.62	0.77	0.60	0.71*	0.50	0.60	0.42	0.56	0.17	0.37	0.67	0.81
	Manual	0.73*	0.82	0.59	0.77	0.61	0.76	0.58	0.67*	0.50	0.64	0.42	0.60	0.18	0.43	0.67	0.77
	Other	0.71*	0.82	0.62	0.78	0.59	0.80	0.60	0.75*	0.52	0.69	0.42	0.62	0.18	0.45	0.66	0.77
Monthly income	Less than 2.5 million won	0.71*	0.78**	0.59	0.74	0.61	0.75	0.59	0.69*	0.51	0.65*	0.40	0.59	0.16	0.41	0.69	0.72**
	2.5–5.0 million won	0.73*	0.84**	0.61	0.77	0.59	0.78	0.59	0.69*	0.50	0.64*	0.43	0.60	0.18	0.42	0.65	0.78**
	>5.0 million won	0.78*	0.90**	0.63	0.84	0.64	0.79	0.62	0.80*	0.51	0.75*	0.43	0.62	0.21	0.47	0.68	0.88**
Ambulatory care visit in past 2 weeks	Yes	0.74	0.78*	0.62	0.78	0.58	0.77	0.61	0.76	0.52	0.66	0.41	0.60	0.20	0.37	0.71*	0.71
Ambulatory care visit in past 2 weeks	No	0.73	0.84*	0.61	0.77	0.61	0.77	0.59	0.70	0.50	0.65	0.42	0.60	0.18	0.43	0.66*	0.78
Hospitalised in past 12 months	Yes	0.74	0.90	0.57	0.84	0.61	0.83	0.68	0.84	0.59	0.61	0.51*	0.61	0.23	0.44	0.62	0.82
Hospitalised in past 12 months	No	0.73	0.83	0.61	0.77	0.60	0.77	0.59	0.70	0.50	0.65	0.42*	0.60	0.18	0.42	0.66	0.78
Morbidity	Yes	0.77	0.86	0.64	0.79	0.63	0.78	0.59	0.73	0.49	0.59	0.38*	0.62	0.14*	0.43	0.72*	0.77
Morbidity	No	0.73	0.83	0.60	0.77	0.60	0.77	0.59	0.70	0.51	0.66	0.43*	0.59	0.19*	0.42	0.65*	0.78

VAS visual analogue scale, SG standard gamble
*P-value < 0.05; **P-value < 0.01

Back to article page

ISSN: 1477-7525

Contact us

Submission enquiries: journalsubmissions@springernature.com